custom image

Tumor Metabolism and the Microenvironment

January 25-28, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET*
*Program is in development and subject to change


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.

 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries

Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.

Apply Here

As we know, cancer is a major cause of mortality worldwide. Furthermore, cancers result from mutations within somatic cells; however, their evolution and phenotype are determined by their environment, both local and systemic. Increased understanding of mechanisms that drive cancer will provide new avenues to reduce incidence and to treat the disease. Therefore, this meeting brings together researchers focusing on how nutrient availability and utilization influences tumors and those thinking about the multitude of inter-cellular interactions occurring within tumors. The inter-connections between these fields are becoming ever more apparent and this meeting unites the fields of tumor metabolism and the tumor microenvironment together, sparking new synergies and connectivity between researchers. With the extensive opportunities for discussion and numerous short talk slots on the program, this conference will help nurture early career scientists, the next generation of talent, and lead to the emergence of collaborative networks. Moreover, there is an afternoon workshop on “Transitioning to Independence” for early career researchers. Finally, a thorough understanding of how tumor systems can adapt and re-wire in response to challenges is needed to ensure that new therapies being developed have the best chance of success as they enter clinical trials. To that end, several speakers have been selected with the expectation that they discuss either clinical trial data. This will strengthen the linkage between cutting-edge mechanistic studies and human disease.

Apply Here for Free On Demand Access


Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD


Abstract Submission:
‣ For Short Talk Consideration: Passed
‣ For Poster Booth: Passed
ePoster / SciTalk Submission: January 14, 2021*
Financial Aid Application: Passed

*Please note, abstract submission is required
in order to submit an ePoster and/or Scitalk


Program Details

Speaking at this eSymposia

Donita C. Brady

University of Pennsylvania, USA

Lewis C. Cantley

Weill Cornell Medicine, USA

Navdeep S. Chandel

Northwestern University, USA

Heather Christofk

University of California, Los Angeles, USA

Karin E. de Visser

Netherlands Cancer Institute, Netherlands

Ralph J. DeBerardinis

University of Texas Southwestern Medical Center, USA

Mikala Egeblad

Cold Spring Harbor Laboratory, USA

Sarah-Maria Fendt

VIB Leuven, Belgium

Johanna A. Joyce

University of Lausanne, Switzerland

Alec Kimmelman

New York University Langone Medical Center, USA

Matthew F. Krummel

University of California, San Francisco, USA

Costas A. Lyssiotis

University of Michigan, USA

Michael E. Pacold

New York University Medical Center, USA

Erika L. Pearce

Max Planck Institute of Immunobiology and Epigenetics, Germany

Erik A. Sahai

Francis Crick Institute, UK

Ruth Scherz-Shouval

Weizmann Institute of Science, Israel

Mara H. Sherman

Oregon Health & Science University, USA

M. Celeste Simon

University of Pennsylvania, USA

Shannon J. Turley

Genentech, Inc., USA

Matthew G. Vander Heiden

Massachusetts Institute of Technology, USA

Karen H. Vousden

Francis Crick Institute, UK

Valerie M. Weaver

University of California, San Francisco, USA

Eileen P. White

Rutgers University, USA

Frank Winkler

University Hospital Heidelberg, Germany


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.

The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.

Related Keystone Symposia In-Person Meetings

Explore all cancer-related meetings on the Keystone Symposia website.

custom image

custom image

custom image

Donate to Keystone Symposia

custom image